Ttbio Corp. (TPEX:6493)
Taiwan · Delayed Price · Currency is TWD 34.95
+0.05 (0.14%)
Oct 8, 2026, 1:24 PM CST
Ttbio Market Cap
Ttbio has a market cap or net worth of 1.05 billion as of October 9, 2026. It is the 33,531st most valuable company in the world and the 2,029th biggest in Taiwan. Its market cap has decreased by 31.74% in one year.
Market Cap
1.05B
Enterprise Value
1.18B
Revenue
433.42M
Global Rank
Country Rank
#2,029 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 8, 2015, Ttbio's market cap has decreased from 1.19B to 1.05B, a decrease of -11.78%. That is a compound annual growth rate of -1.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.05B | 28.97% |
| Dec 31, 2025 | 814.36M | 70.16% |
| Dec 30, 2024 | 478.60M | -8.92% |
| Dec 26, 2023 | 525.49M | -19.22% |
| Dec 28, 2022 | 650.55M | 21.30% |
| Dec 30, 2021 | 536.32M | 2.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ICARES Medicus | 3.73B |
| Maxigen Biotech | 3.42B |
| Nang Kuang Pharmaceutical | 3.36B |
| SciVision Biotech | 3.12B |
| Crystalvue Medical | 1.88B |
| BenQ Medical Technology | 1.78B |
| Chi Sheng Pharma & Biotech | 1.74B |
| Lagis Enterprise | 1.16B |